Galan, JE, et al.
Bacterial type III secretion systems: specialized nanomachines for protein delivery into target cells. Annual Review of Microbiology
2014; 68: 415–438.
Raymond, B, et al.
Subversion of trafficking, apoptosis, and innate immunity by type III secretion system effectors. Trends in Microbiology
2013; 21: 430–441.
Moest, TP, Meresse, S.
Salmonella T3SSs: successful mission of the secret(ion) agents. Current Opinion in Microbiology
2013; 16: 38–44.
Franzin, FM, Sircili, MP. Locus of enterocyte effacement: a pathogenicity island involved in the virulence of enteropathogenic and enterohemorragic Escherichia coli subjected to a complex network of gene regulation. Biomed Research International
2015; 2015: 534738.
Hayashi, T, et al.
Complete genome sequence of enterohemorrhagic Escherichia coli O157:H7 and genomic comparison with a laboratory strain K-12. DNA Research
2001; 8: 11–22.
Ren, CP, et al.
The ETT2 gene cluster, encoding a second type III secretion system from Escherichia coli, is present in the majority of strains but has undergone widespread mutational attrition. Journal of Bacteriology
2004; 186: 3547–3560.
Zhou, M, et al.
Escherichia coli type III secretion system 2: a new kind of T3SS?
2014; 45: 32.
Zhang, L, et al.
Regulators encoded in the Escherichia coli type III secretion system 2 gene cluster influence expression of genes within the locus for enterocyte effacement in enterohemorrhagic E. coli O157:H7. Infection and Immunity
2004; 72: 7282–7293.
Sheikh, J, et al.
EilA, a HilA-like regulator in enteroaggregative Escherichia coli
. Molecular Microbiology
2006; 61: 338–350.
Ideses, D, et al.
A degenerate type III secretion system from septicemic Escherichia coli contributes to pathogenesis. Journal of Bacteriology
2005; 187: 8164–8171.
Yao, Y, et al.
The type III secretion system is involved in the invasion and intracellular survival of Escherichia coli K1 in human brain microvascular endothelial cells. FEMS Microbiology Letters
2009; 300: 18–24.
Cheng, D, et al.
Prevalence and isoforms of the pathogenicity island ETT2 among Escherichia coli isolates from colibacillosis in pigs and mastitis in cows. Current Microbiology
2012; 64: 43–49.
Prager, R, et al.
Prevalence and deletion types of the pathogenicity island ETT2 among Escherichia coli strains from oedema disease and colibacillosis in pigs. Veterinary Microbiology
2004; 99: 287–294.
Osawa, K, et al.
Identification of the ETT2 locus in human diarrheagenic Escherichia coli by multiplex PCR. Journal of Infection and Chemotherapy
2006; 12: 157–159.
Miyazaki, J, et al.
Identification of a type III secretion system in uropathogenic Escherichia coli
. FEMS Microbiology Letters
2002; 212: 221–228.
Tivendale, KA, et al.
Avian-pathogenic Escherichia coli strains are similar to neonatal meningitis E. coli strains and are able to cause meningitis in the rat model of human disease. Infection and Immunity
2010; 78: 3412–3419.
Ewers, C, et al.
Avian pathogenic, uropathogenic, and newborn meningitis-causing Escherichia coli: how closely related are they?
International Journal of Medical Microbiology
2007; 297: 163–176.
Johnson, TJ, et al.
Comparison of extraintestinal pathogenic Escherichia coli strains from human and avian sources reveals a mixed subset representing potential zoonotic pathogens. Applied and Environmental Microbiology
2008; 74: 7043–7050.
Wang, S, et al.
DotU expression is highly induced during in vivo infection and responsible for virulence and Hcp1 secretion in avian pathogenic Escherichia coli
. Frontiers in Microbiology
2014; 5: 588.
Wang, S, et al.
Development of an allele-specific PCR assay for simultaneous sero-typing of avian pathogenic Escherichia coli predominant O1, O2, O18 and O78 strains. PLoS ONE
2014; 9: e96904.
Clermont, O, Bonacorsi, S, Bingen, E. Rapid and simple determination of the Escherichia coli phylogenetic group. Applied and Environmental Microbiology
2000; 66: 4555–4558.
Meng, Q, et al.
Development and application of multiplex PCR assay for detection of virulence genes in Avian pathogenic E. coli.
Acta Microbiologica Sinica
2014; 54: 696–702.
Chaudhuri, RR, et al.
Complete genome sequence and comparative metabolic profiling of the prototypical enteroaggregative Escherichia coli strain 042. PLoS ONE
2010; 5: e8801.
Rodriguez-Siek, KE, et al.
Comparison of Escherichia coli isolates implicated in human urinary tract infection and avian colibacillosis. Microbiology
2005; 151: 2097–2110.
Brown, NF, Finlay, BB. Potential origins and horizontal transfer of type III secretion systems and effectors. Mobile Genetic Elements
2011; 1: 118–121.
Schmidt, H, et al.
Identification and characterization of a novel genomic island integrated at selC in locus of enterocyte effacement-negative, Shiga toxin-producing Escherichia coli
. Infection and Immunity
2001; 69: 6863–6873.
Makino, S, et al.
Distribution of the secondary type III secretion system locus found in enterohemorrhagic Escherichia coli O157:H7 isolates among Shiga toxin-producing E. coli strains. Journal of Clinical Microbiology
2003; 41: 2341–2347.
Lee, VT, Kessler, JL. Type III secretion systems as targets for novel therapeutics. IDrugs
2009; 12: 636–641.